Neurobrucellosis: Clinical and diagnostic features

Clinical Infectious Diseases

Volumn 56, Issue 10, 2013, Pages 1407-1412

  Guven, Tumer ^a   Ugurlu, Kenan ^b   Ergonul, Onder ^c   Celikbas, Aysel Kocagul ^d   Gok, Sebnem Eren ^d   Comoglu, Selcuk ^e   Baykam, Nurcan ^d   Dokuzoguz, Basak ^d  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b 25 Aralik Community Hospital   (Turkey)

^c KOÇ UNIVERSITY   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e Research Hospital   (Turkey)

Author keywords

clinical; diagnosis; epidemiology; neurobrucellosis

Indexed keywords

ADULT; AGITATION; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIUM ISOLATION; BEHAVIOR DISORDER; BRUCELLA; BRUCELLOSIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CRANIAL NEUROPATHY; DISORIENTATION; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LUMBAR PUNCTURE; LYMPHOCYTOSIS; MALE; MUSCLE WEAKNESS; NEUROBRUCELLOSIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TESTS; BRUCELLA; BRUCELLOSIS; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; TREATMENT OUTCOME; TURKEY;

EID: 84877251053     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit072     Document Type: Article

References (33)

1. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone, 2010:2921-5.
2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325-36.
3. Finn TB. Brucellosis. In: Cohen J, Powderly WG, eds. Infectious diseases. 2nd ed. New York: Elsevier, 2004:1665-9.
4. Solera J, Martinez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 1997; 53:245-56.
5. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992; 15:582-90.
6. Eren S, Bayam G, Ergonul O, et al. Cognitive and emotional changes in neurobrucellosis. J Infect 2006; 53:184-9.
7. Bodur H, Erbay A, Akinci E, Colpan A, Cevik MA, Balaban N. Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis 2003; 35:94-7.
8. Karsen H, Akdeniz H, Karahocagil MK, Irmak H, Sunnetcioglu M. Toxic-febrile neurobrucellosis, clinical findings and outcome of treatment of four cases based on our experience. Scand J Infect Dis 2007; 39:990-5.
9. Sanchez-Sousa A, Torres C, Campello MG, et al. Serological diagnosis of neurobrucellosis. J Clin Pathol 1990; 43:79-81.
10. Yetkin MA, Bulut C, Erdinc FS, Oral B, Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis 2006; 10: 446-52.
11. Young DA. Florence Nightingale's fever. BMJ 1995; 311:1697-700.
12. Aydin E. Epidemiology of Brucella infections in Turkey. In: Fourth Symposium on Zoonotic Diseases in Turkey. Ankara, 2012:57-63.
13. Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis. A report on 19 cases. Brain 1987; 110(Pt 1):213-23.
14. Lubani MM, Dudin KI, Araj GF, Manandhar DS, Rashid FY. Neurobrucellosis in children. Pediatr Infect Dis J 1989; 8:79-82.
15. Solaroglu I, Kaptanoglu E, Okutan O, Beskonakli E. Solitary extraaxial posterior fossa abscess due to neurobrucellosis. J Clin Neurosci 2003; 10:710-2.
16. Tonekaboni SH, Karimi A, Armin S, Khase LA, Sabertehrani AS. Neurobrucellosis: a partially treatable cause of vision loss. Pediatr Neurol 2009; 40:401-3.
17. Sturniolo G, Mondello P, Bruno S, et al. Neurobrucellosis associated with syndrome of inappropriate antidiuretic hormone with resultant diabetes insipidus and hypothyroidism. J Clin Microbiol 2010; 48: 3806-9.
18. Ay S, Tur BS, Kutlay S. Cerebral infarct due to meningovascular neurobrucellosis: a case report. Int J Infect Dis 2010; 14(suppl 3):e202-4.
19. Ahmed R, Patil BS. Neurobrucellosis: a rare cause for spastic paraparesis. Braz J Infect Dis 2009; 13:245.
20. Akdeniz H, Irmak H, Anlar O, Demiroz AP. Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect 1998; 36:297-301.
21. Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 2009; 13:e339-43.
22. Hatipoglu CA, Yetkin A, Ertem GT, Tulek N. Unusual clinical presentations of brucellosis. Scand J Infect Dis 2004; 36:694-7.
23. Kochar DK, Kumawat BL, Agarwal N, et al. Meningoencephalitis in brucellosis. Neurol India 2000; 48:170-3.
24. Tekin-Koruk S, Duygu F, Gursoy B, Karaagac L, Bayraktar M. A rare case of seronegative neurobrucellosis. Ann Saudi Med 2010; 30:412-4.
25. Mousa AR, Koshy TS, Araj GF, et al. Brucella meningitis: presentation, diagnosis and treatment-a prospective study of ten cases. Q J Med 1986; 60:873-85.
26. Araj GF, Lulu AR, Saadah MA, Mousa AM, Strannegard IL, Shakir RA. Rapid diagnosis of central nervous system brucellosis by ELISA. J Neuroimmunol 1986; 12:173-82.
27. Ciftci C, Ozturk F, Oztekin A, et al. Comparison of the serological tests used for the laboratory diagnosis of brucellosis [in Turkish]. Mikrobiyol Bul 2005; 39:291-9.
28. Bashir R, Al-Kawi MZ, Harder EJ, Jinkins J. Nervous system brucellosis: diagnosis and treatment. Neurology 1985; 35:1576-81.
29. Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther 2007; 5:983-90.
30. Bahemuka M, Shemena AR, Panayiotopoulos CP, Al-Aska AK, Obeid T, Daif AK. Neurological syndromes of brucellosis. J Neurol Neurosurg Psychiatry 1988; 51:1017-21.
31. Baykam N, Esener H, Ergonul O, Eren S, Celikbas AK, Dokuzoguz B. In vitro antimicrobial susceptibility of Brucella species. Int J Antimicrob Agents 2004; 23:405-7.
32. Bouza E, Garcia de la Torre M, Parras F, Guerrero A, Rodriguez-Creixems M, Gobernado J. Brucellar meningitis. Rev Infect Dis 1987; 9:810-22.
33. Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 2012; 56:1523-8.